Continuous vs High-Intensity Interval Exercise in COPD

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-centre, randomized cross-over trial in COPD patients to compare acute changes in cerebral oxygenation, cardiopulmonary exercise testing parameters, systemic hemodynamics, and autonomic responses following two exercise modalities. Participants complete baseline assessments before undergoing both moderate intensity continuous aerobic exercise and high-intensity interval aerobic exercise in separate visits. Measurements include arterial blood gases, spirometry, DLCO, lung volumes, blood pressure, and autonomic markers collected around exercise sessions. The trial aims to clarify how different training formats might influence cerebral oxygen delivery during exercise in COPD, potentially informing rehabilitation strategies.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Clinical diagnosis of COPD based on smoking history (pack/years) or exposure to other risk factors and post bronchodilation forced expiratory volume (FEV1) to forced vital capacity (FVC) ratio \<0.7
* Resting arterial oxygen partial pressure at room air \>60 mmHg, according to recent (within a week) arterial blood gases assessment
* Disease being stable and treated optimal, based on current GOLD guidelines.
* Provision of informed written signed consent prior to study entry

Exclusion Criteria:

* Recent respiratory infection or exacerbation (as indicated by deterioration of respiratory symptoms, hospital admission and/or change in medication within the previous month), within the past 3 months
* Changes in COPD medication with the past month
* History of asthma and/or reversible airway obstruction (post bronchodilation FEV1/ FVC \>0.7)
* Pulmonary hypertension
* Congestive heart failure (Left Ventricle Ejection Fraction \<50% in recent echocardiography)
* Severe peripheral artery disease
* Chronic Kidney disease with eGFR \< 30 ml/min (KDIGO stages 3b, 4 ,5)
* Active acute or chronic infectious diseases
* Active malignant disease or hematologic disorder under treatment
* History of neuromuscular disorder
* History of severe intellectual disability or mental disorder
* Any contradiction to moderate-high intensity exercise or cardiopulmonary exercise testing according to ATS/ACCP guidelines, such as: myocardial infarction within the past 6 months, unstable angina, syncope, symptomatic severe aortic stenosis, uncontrolled arrhythmias causing symptoms or hemodynamic compromise, acute pulmonary embolus or pulmonary infarction, thrombosis of lower extremities, suspected dissecting aneurysm, pulmonary edema, severe untreated arterial hypertension at rest (\> 200 mm Hg systolic, \> 120 mm Hg diastolic blood pressure), orthopedic impairment that compromises exercise performance.

Where it's running

• George Papanikolaou General Hoapital of Thessaloniki
  Thessaloniki, Exohi, Greece Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer

  This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.

  Recruiting Phase 2 AeroRx Therapeutics Inc. · London and 1 other locations · NCT07896252

• Cognitive load and inhaler technique in COPD

  This study tests whether adding a short memory task while using an inhaler makes COPD patients more likely to misuse their inhaler.

  Recruiting Spitalul Clinic de Boli Infecțioase și Pneumoftiziologie Dr. Victor Babeș Timișoara · Timișoara, Timiș County · NCT07786220

• Balance training after pulmonary rehab for COPD to help steadiness and reduce falls

  A COPD-focused balance training program called Sport4Steadiness is being tested to see if people with COPD will accept it and if the study processes work well.

  Recruiting at 3 sites Teesside University · Middlesbrough and 2 other locations · NCT07750821

• Biomarker clues for COPD, IPF, and lung cancer

  This study tests whether inflammation, immune, genetic, and epigenetic markers at enrollment can explain how COPD, IPF, or lung cancer present and behave, in order to see if these markers can predict outcomes over a year.

  Recruiting Fondazione Don Carlo Gnocchi ETS · Milan, Milan · NCT07707245

• HRS-9821 Inhalation Suspension for COPD: Safety and Dose Finding in Adults

  This study tests whether HRS-9821 inhalation can be safely taken and help people with moderate to severe COPD, and aims to find a reasonable dose.

  Recruiting Phase 2 Guangdong Hengrui Pharmaceutical Co., Ltd · Shanghai, Shanghai Municipality · NCT07640451

• Relaxation techniques for anxiety and sleep in COPD patients

  This study tests whether Laura Mitchell’s relaxation technique or Benson’s relaxation response can help reduce anxiety, improve sleep, and lessen fatigue in adults with COPD.

  Recruiting Riphah International University · Lahore, Punjab Province · NCT07635446

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.